UK Trade & Investment — the business development arm of the British Consulate — invited DevicePharm CEO & Chief Strategy Officer, Clay Wilemon, to present to UK medical firms during a February conference.
Any marketer that has conducted a direct-to-consumer (DTC) campaign understands the challenge of consumer engagement, especially web engagement. How do you meaningfully engage with interested visitors who are browsing your website in a world of 24/7 communication expectations?
Healthcare reform is changing the way that healthcare marketers think about everything from clinical trials to product launches. New payment models, new delivery models, and HEOR mandates are all creating major changes in marketing focus for medical device, biotech, pharmaceutical, and medical diagnostics companies.
At the 2015 San Antonio Breast Cancer Symposium, Provista introduced Videssa® Breast, a breakthrough that accurately detects the presence or absence of breast cancer with a protein-based blood test. Videssa® Breast provides clinicians, and their patients, with clinical confidence, clarity and peace-of-mind about what to do next when mammography is unclear – detecting the absence or presence of breast cancer by identifying early warning signals called biomarkers.
Millions of Americans have considered weight loss surgery but made the decision that although they wanted significant weight loss, surgery was too big of a step for them. Now, with the U.S. FDA’s approval of the ReShape™ Integrated Dual Balloon System, a non-surgical weight loss procedure is available in the United States. It is called theReShape Procedure and is indicated for people with a BMI of 30 to 40.
The mindset a few years ago for website development was to consider how a digital property was going to look on a mobile device. As responsive design became a reality, the logic shifted to one focused on providing a quality mobile user experience . Now, with mobile usage far surpassing computer usage for initial searches, we have to have a mobile optimized mindset as we create content for healthcare professionals.
What if you could focus your marketing plans and messaging only on the people who were actually going to buy your product or service?” This was the question posed by Clay Wilemon, DevicePharm CEO & Chief Strategy Officer, to an enthusiastic audience in San Diego during the September Device Alliance meeting.
The reality is that using predictive analytics in market research is providing a more precise way of targeting, messaging, and selling to the customers who are actually going to buy your products.
Bausch + Lomb is an iconic brand with both consumers and eye care professionals. The company launched their new Bausch + Lomb Surgical corporate campaign at the 2015 ASCRS meeting in San Diego. This campaign reflects an expanded portfolio of differentiated technologies and services for ophthalmic surgeons.
Medical device and pharmaceutical companies spend billions of dollars each year trying to reach, educate, and influence physicians and surgeons. In the past, it was easy – just send a sales rep to the office, take lunch, and tell the physicians and staff about your product.
“Do we really need sales reps to support medical devices?” This question has been asked by surgeons, medical device CEOs, and hospital administrators for years. Recently, however, that philosophical question moved from theory to practice in a bold move by Smith & Nephew.